LONDON – Final results of the community pilot in Liverpool, U.K., that used the controversial Innova Medical Group Inc. lateral flow device to test all comers for COVID-19, show new cases fell by 21% compared to other areas of the U.K., because infections were detected early and people quarantined sooner.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Athenex, Immutep, Janssen-Cilag, Levo, Merck, Opthea, Orgenesis, Sciclone, Y-Mabs.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alexion, Aspire Health Science, Astrazeneca, Biohaven, Dare Bioscience, Eisbach, Eli Lilly, Everest Medicines, Hemostemix, Kura Oncology, Mina, Novartis, Pfizer, Spero, Ultimovacs.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apeiron, Athira, Boehringer Ingelheim, Clover, Eiger, Eli Lilly, Hutchmed, Innate, Longeveron, Marker, Trillium, Ysopia.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Clinical Laserthermia Systems, Longhorn Vaccines & Diagnostics, Moleculight, Philips, Viewray.
PERTH, Australia – Rapid point-of-care (POC) diagnostics company Lumos Diagnostics Holdings Ltd. completed a A$63 million (US$47.44 million) initial public offering (IPO) on the Australian Securities Exchange (ASX) on July 5. “The funds raised will support U.S. commercialization of Febridx, to build our pipeline and to expand our operations so that we have the facilities and infrastructure in place to do automated assembly and manufacturing,” Lumos Diagnostics CEO Rob Sambursky told BioWorld.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advicenne, Agenus, Bristol Myers Squibb, Cytodyn, Diurnal, Hangzhou Chance, Iterum, Moderna, Recipharm, Zydus Cadila.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4D, Agenus, Arbutus, Auris, BMS, Cellgenix, Defence, Destiny, Denovo, Lipidor, Lundbeck, Mandos, Merck, Regeneron, Sartorius, SK Chemicals, Standigm, Vaccitech, Vtesse.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arrowhead, Gan and Lee, J&J, Krystal, Nicox, Philogen, Rallybio, Roche, Sab, Transcenta, Zydus.
RSS
